Edwards Lifesciences Corp. (EW)
104.37
+0.36
(+0.35%)
USD |
NYSE |
Nov 11, 10:18
Edwards Lifesciences Net Income (TTM) : 987.70M for Sept. 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 987.70M |
| June 30, 2026 | 978.60M |
| March 31, 2026 | 1.073B |
| December 31, 2025 | 1.056B |
| September 30, 2025 | 1.337B |
| June 30, 2025 | 1.407B |
| March 31, 2025 | 1.435B |
| December 31, 2024 | 1.396B |
| September 30, 2024 | 1.384B |
| June 30, 2024 | 1.357B |
| March 31, 2024 | 1.247B |
| December 31, 2023 | 1.263B |
| September 30, 2023 | 1.328B |
| June 30, 2023 | 1.337B |
| March 31, 2023 | 1.489B |
| December 31, 2022 | 1.522B |
| September 30, 2022 | 1.459B |
| June 30, 2022 | 1.455B |
| March 31, 2022 | 1.538B |
| December 31, 2021 | 1.503B |
| September 30, 2021 | 1.477B |
| June 30, 2021 | 1.462B |
| March 31, 2021 | 851.00M |
| December 31, 2020 | 823.40M |
| September 30, 2020 | 794.10M |
| Date | Value |
|---|---|
| June 30, 2020 | 743.60M |
| March 31, 2020 | 1.108B |
| December 31, 2019 | 1.047B |
| September 30, 2019 | 773.70M |
| June 30, 2019 | 724.90M |
| March 31, 2019 | 765.30M |
| December 31, 2018 | 722.20M |
| September 30, 2018 | 712.40M |
| June 30, 2018 | 656.60M |
| March 31, 2018 | 560.00M |
| December 31, 2017 | 583.60M |
| September 30, 2017 | 744.90M |
| June 30, 2017 | 716.20M |
| March 31, 2017 | 656.70M |
| December 31, 2016 | 569.50M |
| September 30, 2016 | 551.70M |
| June 30, 2016 | 528.40M |
| March 31, 2016 | 514.50M |
| December 31, 2015 | 494.90M |
| September 30, 2015 | 463.40M |
| June 30, 2015 | 439.90M |
| March 31, 2015 | 874.20M |
| December 31, 2014 | 811.10M |
| September 30, 2014 | 777.70M |
| June 30, 2014 | 760.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Intuitive Surgical, Inc. | 2.973B |
| Stryker Corp. | 3.623B |
| Abbott Laboratories | 4.725B |
| Boston Scientific Corp. | 3.494B |
| Glaukos Corp. | -169.80M |